ATOSSA THERAPEUTICS, INC. (ATOS) › Capital ExpendituresATOSSA THERAPEUTICS, INC. (ATOS) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $110.9K2019: $7.6K2020: $9.0K2021: $9.0K2022: $27.0K2023: $14.0K2024: $19.0K2025: $23.0K$23.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$23.0K+21.1%2024$19.0K+35.7%2023$14.0K-48.1%2022$27.0K+200.0%2021$9.0K+0.0%2020$9.0K+18.0%2019$7.6K-93.1%2018$110.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share